Cargando…

High plasma homocysteine and insulin resistance in patients with polycystic ovarian syndrome

BACKGROUND: Polycystic ovarian syndrome (PCOS) is a common disease among women in fertility ages and cause severe insulin resistance. Hyperhomocysteinaemia is said to be among the features of PCOS that could influence its outcome. OBJECTIVE: This study aimed to investigate whether hyperhomocysteinae...

Descripción completa

Detalles Bibliográficos
Autores principales: Hemati, Tayebe, Moghadami-Tabrizi, Nasrin, Davari-Tanha, Fateme, Salmanian, Bahram, Javadian, Pouya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Research and Clinical Center for Infertility 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4575758/
https://www.ncbi.nlm.nih.gov/pubmed/26396568
_version_ 1782390813880221696
author Hemati, Tayebe
Moghadami-Tabrizi, Nasrin
Davari-Tanha, Fateme
Salmanian, Bahram
Javadian, Pouya
author_facet Hemati, Tayebe
Moghadami-Tabrizi, Nasrin
Davari-Tanha, Fateme
Salmanian, Bahram
Javadian, Pouya
author_sort Hemati, Tayebe
collection PubMed
description BACKGROUND: Polycystic ovarian syndrome (PCOS) is a common disease among women in fertility ages and cause severe insulin resistance. Hyperhomocysteinaemia is said to be among the features of PCOS that could influence its outcome. OBJECTIVE: This study aimed to investigate whether hyperhomocysteinaemia exists in PCOS and if it is related to insulin resistance in the affected patients. MATERIALS AND METHODS: This prospective study was carried out in a university based fertility clinic. Sixty four PCOS patients and 50 normo ovulatory controls were reviewed for fasting glucose, insulin, homocysteine, luteinizing hormone (LH), and follicle-stimulating hormone (FSH) plasma levels in the blood sample of the 3(rd) day of their menstrual cycle. Insulin resistance was determined with the fasting glucose (mmol/L) to insulin (mIU/L) ratio and HOMA-IR (Homeostasis model assessment-Insulin resistance). Independent-samples T-test and linear regression test were utilized to analyze the obtained data. RESULTS: Homocysteine levels compared between PCOS patients and control group showed a significant difference. PCOS group was divided into insulin resistant (IR) (LogHOMA-IR≥0.57) and non insulin resistant (NIR) patients. The IR group had significantly higher homocysteine (p-value=0.02), fasting insulin and glucose levels (p-value<0.001) rather than NIR group. CONCLUSION: PCOS patients have a leaning toward hyperhomocysteinaemia and insulin resistance. Insulin resistant patients are found to have higher homocysteine level.
format Online
Article
Text
id pubmed-4575758
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Research and Clinical Center for Infertility
record_format MEDLINE/PubMed
spelling pubmed-45757582015-09-22 High plasma homocysteine and insulin resistance in patients with polycystic ovarian syndrome Hemati, Tayebe Moghadami-Tabrizi, Nasrin Davari-Tanha, Fateme Salmanian, Bahram Javadian, Pouya Iran J Reprod Med Original Article BACKGROUND: Polycystic ovarian syndrome (PCOS) is a common disease among women in fertility ages and cause severe insulin resistance. Hyperhomocysteinaemia is said to be among the features of PCOS that could influence its outcome. OBJECTIVE: This study aimed to investigate whether hyperhomocysteinaemia exists in PCOS and if it is related to insulin resistance in the affected patients. MATERIALS AND METHODS: This prospective study was carried out in a university based fertility clinic. Sixty four PCOS patients and 50 normo ovulatory controls were reviewed for fasting glucose, insulin, homocysteine, luteinizing hormone (LH), and follicle-stimulating hormone (FSH) plasma levels in the blood sample of the 3(rd) day of their menstrual cycle. Insulin resistance was determined with the fasting glucose (mmol/L) to insulin (mIU/L) ratio and HOMA-IR (Homeostasis model assessment-Insulin resistance). Independent-samples T-test and linear regression test were utilized to analyze the obtained data. RESULTS: Homocysteine levels compared between PCOS patients and control group showed a significant difference. PCOS group was divided into insulin resistant (IR) (LogHOMA-IR≥0.57) and non insulin resistant (NIR) patients. The IR group had significantly higher homocysteine (p-value=0.02), fasting insulin and glucose levels (p-value<0.001) rather than NIR group. CONCLUSION: PCOS patients have a leaning toward hyperhomocysteinaemia and insulin resistance. Insulin resistant patients are found to have higher homocysteine level. Research and Clinical Center for Infertility 2011 /pmc/articles/PMC4575758/ /pubmed/26396568 Text en This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Hemati, Tayebe
Moghadami-Tabrizi, Nasrin
Davari-Tanha, Fateme
Salmanian, Bahram
Javadian, Pouya
High plasma homocysteine and insulin resistance in patients with polycystic ovarian syndrome
title High plasma homocysteine and insulin resistance in patients with polycystic ovarian syndrome
title_full High plasma homocysteine and insulin resistance in patients with polycystic ovarian syndrome
title_fullStr High plasma homocysteine and insulin resistance in patients with polycystic ovarian syndrome
title_full_unstemmed High plasma homocysteine and insulin resistance in patients with polycystic ovarian syndrome
title_short High plasma homocysteine and insulin resistance in patients with polycystic ovarian syndrome
title_sort high plasma homocysteine and insulin resistance in patients with polycystic ovarian syndrome
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4575758/
https://www.ncbi.nlm.nih.gov/pubmed/26396568
work_keys_str_mv AT hematitayebe highplasmahomocysteineandinsulinresistanceinpatientswithpolycysticovariansyndrome
AT moghadamitabrizinasrin highplasmahomocysteineandinsulinresistanceinpatientswithpolycysticovariansyndrome
AT davaritanhafateme highplasmahomocysteineandinsulinresistanceinpatientswithpolycysticovariansyndrome
AT salmanianbahram highplasmahomocysteineandinsulinresistanceinpatientswithpolycysticovariansyndrome
AT javadianpouya highplasmahomocysteineandinsulinresistanceinpatientswithpolycysticovariansyndrome